As neoplasias hematológicas apresentam elevado potencial de dano sistêmico ao
indivíduo, sendo capazes de desencadear sérias condições de saúde. A quimioterapia …

Cancer rehabilitation aims to enable patients to maximize their physical, social,
psychological, and vocational functions within the limits that arise during the course of the …

Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of several
chemotherapeutic agents, such as Paclitaxel. The main symptoms of CIPN are pain and …

Several studies investigated the side effect of adjuvant cancer treatments, and different types
of preventive techniques or treatments have been assessed. Chemotherapy-induced …

Introduction Paclitaxel can cause peripheral neuropathy in up to 60% of patients.
Chemotherapy-induced peripheral neuropathy (CIPN) compromises quality of life and often …

Background outcome of patients who develop resectable metachronous colorectal liver
metastases (CLM) after adjuvant oxaliplatin‐based chemotherapy for Stage III colorectal …

Peripheral neuropathy is one of the most common side-effects experienced by cancer
patients treated with chemotherapy. Children treated for ALL are no exception with VIPN …

Taxanes are key drugs for patients with breast cancer. A major adverse effect of taxanes is
peripheral neuropathy (PN). To investigate the ability of compression therapy using sleeves …

Vincristine-induced peripheral neuropathy (VIPN) is the main side effect and major reason
for neuropathic pain in cancer survivors treated with vincristine. Vincristine, a …

All chemotherapy drugs work by decreasing cellular growth and proliferation. The
mechanisms of these drugs vary from competitively inhibiting cross-linking DNA, to blocking …